IBDEI1JS ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25875,0)
 ;;=I77.1^^127^1266^143
 ;;^UTILITY(U,$J,358.3,25875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25875,1,3,0)
 ;;=3^Stricture of Artery
 ;;^UTILITY(U,$J,358.3,25875,1,4,0)
 ;;=4^I77.1
 ;;^UTILITY(U,$J,358.3,25875,2)
 ;;=^114763
 ;;^UTILITY(U,$J,358.3,25876,0)
 ;;=I71.2^^127^1266^144
 ;;^UTILITY(U,$J,358.3,25876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25876,1,3,0)
 ;;=3^Thoracic Aortic Aneurysm w/o Rupture
 ;;^UTILITY(U,$J,358.3,25876,1,4,0)
 ;;=4^I71.2
 ;;^UTILITY(U,$J,358.3,25876,2)
 ;;=^5007787
 ;;^UTILITY(U,$J,358.3,25877,0)
 ;;=I71.5^^127^1266^145
 ;;^UTILITY(U,$J,358.3,25877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25877,1,3,0)
 ;;=3^Thoracoabdominal Aortic Aneurysm w/ Rupture
 ;;^UTILITY(U,$J,358.3,25877,1,4,0)
 ;;=4^I71.5
 ;;^UTILITY(U,$J,358.3,25877,2)
 ;;=^5007790
 ;;^UTILITY(U,$J,358.3,25878,0)
 ;;=I71.6^^127^1266^146
 ;;^UTILITY(U,$J,358.3,25878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25878,1,3,0)
 ;;=3^Thoracoabdominal Aortic Aneurysm w/o Rupture
 ;;^UTILITY(U,$J,358.3,25878,1,4,0)
 ;;=4^I71.6
 ;;^UTILITY(U,$J,358.3,25878,2)
 ;;=^5007791
 ;;^UTILITY(U,$J,358.3,25879,0)
 ;;=E10.620^^127^1266^52
 ;;^UTILITY(U,$J,358.3,25879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25879,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Dermatitis
 ;;^UTILITY(U,$J,358.3,25879,1,4,0)
 ;;=4^E10.620
 ;;^UTILITY(U,$J,358.3,25879,2)
 ;;=^5002615
 ;;^UTILITY(U,$J,358.3,25880,0)
 ;;=E10.40^^127^1266^53
 ;;^UTILITY(U,$J,358.3,25880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25880,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,25880,1,4,0)
 ;;=4^E10.40
 ;;^UTILITY(U,$J,358.3,25880,2)
 ;;=^5002604
 ;;^UTILITY(U,$J,358.3,25881,0)
 ;;=E10.51^^127^1266^54
 ;;^UTILITY(U,$J,358.3,25881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25881,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Peripheral Angiopathy w/o Gangrene
 ;;^UTILITY(U,$J,358.3,25881,1,4,0)
 ;;=4^E10.51
 ;;^UTILITY(U,$J,358.3,25881,2)
 ;;=^5002610
 ;;^UTILITY(U,$J,358.3,25882,0)
 ;;=E10.621^^127^1266^56
 ;;^UTILITY(U,$J,358.3,25882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25882,1,3,0)
 ;;=3^Diabetes Type 1 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,25882,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,25882,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,25883,0)
 ;;=E10.65^^127^1266^57
 ;;^UTILITY(U,$J,358.3,25883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25883,1,3,0)
 ;;=3^Diabetes Type 1 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,25883,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,25883,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,25884,0)
 ;;=E10.649^^127^1266^58
 ;;^UTILITY(U,$J,358.3,25884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25884,1,3,0)
 ;;=3^Diabetes Type 1 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,25884,1,4,0)
 ;;=4^E10.649
 ;;^UTILITY(U,$J,358.3,25884,2)
 ;;=^5002622
 ;;^UTILITY(U,$J,358.3,25885,0)
 ;;=E10.618^^127^1266^51
 ;;^UTILITY(U,$J,358.3,25885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25885,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Arthropathy
 ;;^UTILITY(U,$J,358.3,25885,1,4,0)
 ;;=4^E10.618
 ;;^UTILITY(U,$J,358.3,25885,2)
 ;;=^5002614
 ;;^UTILITY(U,$J,358.3,25886,0)
 ;;=E10.638^^127^1266^59
 ;;^UTILITY(U,$J,358.3,25886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25886,1,3,0)
 ;;=3^Diabetes Type 1 w/ Oral Complications
 ;;^UTILITY(U,$J,358.3,25886,1,4,0)
 ;;=4^E10.638
 ;;^UTILITY(U,$J,358.3,25886,2)
 ;;=^5002620
 ;;^UTILITY(U,$J,358.3,25887,0)
 ;;=E10.628^^127^1266^61
 ;;^UTILITY(U,$J,358.3,25887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25887,1,3,0)
 ;;=3^Diabetes Type 1 w/ Skin Complications
